In the compelling follow-up to the award-winning documentary, BURZYNSKI (2010); BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II (2013) continues its exposé on a controversial cancer therapy (Antineoplastons) which was approved for clinical trials by America's FDA after the agency failed to have its inventor (Dr Stanislaw Burzynski) incarcerated—and follows the turbulent journeys of cancer patients undergoing treatment at the Burzynski Clinic in Houston, Texas.
For most of Burzynski's patients, their advanced cancer often runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making foolish treatment decisions—despite mainstream oncology leaving many of them for dead. As the story unfolds, you will observe a real—time change of hearts and minds from many of these doctors and families—as we showcase interviews with oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic.
Since discovering Antineoplastons, Dr. Burzynski has pioneered an expansion of his therapy which he calls "Personalized Gene-Targeted Cancer Therapy", where a treatment regimen of approved drugs is specifically tailored to the mapped genome of an individual patient's cancer—this is in contrast to the "one-size-fits-all" approach that current oncology adheres to. Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America's FDA, this new "personalized gene-targeted" direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski's practice in ways never before thought possible. And yet, remarkably, still with similar resistance and controversy endured by Burzynski's Antineoplastons.
The film takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years, without Dr. Burzynski's involvement or supervision. You'll learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer compounds using their own methodologies, resulting in the first ever independently-run randomized controlled clinical trials.
"After twenty-seven years of independently testing Antineoplastons - including randomized clinical trials, we found that Dr. Burzynski was right.It's obviously not anecdotal anymore." - Hideaki Tsuda, MD, 2013
You also will witness the clandestine tactics used by the medical industry's now usurped regulatory agency to block the Antineoplastons' Phase 3 clinical trial process and see how a group of "information hit men" have been organized to pollute all channels of public information in an effort to confuse the public over the truth behind Antineoplastons. This international group also engages in the intimidation and harassment of prospective and current terminal cancer patients under Dr. Burzynski's care.
However, most notable of all—are the earth-shattering events that occurred upon the final days of the film's production. You'll be left speechless, yet with so much to say, when you witness the story and shocking conclusion to BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II.
"I can't imagine a world where people will not have the privilege that I have had - the privilege to have their life saved by a new technology that can cure cancer - it's terrifying." - Laura Hymas, 2013
© Copyright Merola Productions 2013
More information on BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II is available. Please email Jon Barratt at email@example.com with the nature of your interest and Jon will reply with a link and guest username / password.